Company to Host First Investor Conference Call since August IPO
SAN DIEGO, Nov. 3, 2004 (PRIMEZONE) -- BioMed Realty Trust, Inc. (NYSE:BMR - News) today announced that it will report results for its third quarter ended September 30, 2004 at 5:00 a.m. Pacific Time on Thursday, November 11, 2004.
Alan D. Gold, president and chief executive officer, and John F. Wilson II, chief financial officer, will host an investor conference call the same day at 10:00 a.m. Pacific Time to discuss the company's financial results for the quarter and developments since the company's initial public offering in August 2004.
The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at http://www.biomedrealty.com and http://www.companyboardroom.com, or live by calling (877) 226-4265 with call ID number 1955986. Participants who wish to participate in the live call are encouraged to pre-register by email at firstname.lastname@example.org or by calling (310) 442-9852.
The call will be archived for two weeks on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Thursday, November 11, 2004 through midnight Pacific Time on Tuesday, November 16, 2004 by calling (800) 642-1687 (domestic) or (706) 645-9291 (international) and using access code: 1955986.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is focused on acquiring, owning, leasing, managing and selectively developing laboratory and office space for lease to life science tenants. Tenants include biotechnology and pharmaceutical companies, scientific research institutes, government agencies, physician groups and other entities involved in the life science industry. The company targets properties located in markets with established reputations as centers for scientific research, including San Diego, San Francisco, Seattle, Maryland, Pennsylvania, New York/New Jersey and Boston.
CONTACTS: Maier & Company, Inc.
Gary S. Maier / Sophie Xu
Source: BioMed Realty Trust, Inc.